DRUG: Visilizumab
Help
Entry
D06314 Drug
Name
Visilizumab (USAN/INN);
Nuvion (TN)
Efficacy
Immunosuppressant, Anti-CD3 antibody
Type
Monoclonal antibody
Comment
Treatment of organ transplantation rejection and other T lymphocyte-mediated diseases and disorders, including autoimmune diseases
Target
CD3 [HSA:
915
916
917
] [KO:
K06450
K06451
K06452
]
Pathway
hsa04660
T cell receptor signaling pathway
Brite
Target-based classification of drugs [BR:
br08310
]
Cell surface molecules and ligands
Other cell surface molecules
CD molecules
CD3
D06314 Visilizumab (USAN/INN)
BRITE hierarchy
Other DBs
CAS:
219716-33-3
PubChem:
47207971
LinkDB
All DBs
» Japanese version
» Back
DBGET
integrated database retrieval system